Full View
In the News

Nor-Cal EMS Important News Highlights

Bringing you important news highlights in your North State.

May 23, 2012 - FDA MedWatch - Hospira Carpuject Pre-filled Cartridges

Drug Alert: Products May Contain More Than the Intended Fill Volume

Morphine and Hydromorphone have been on nationwide shortage over the last several months, the FDA advisory below indicates a new concern involving these products that requires immediate attention.

This message indicates there may be lots of Morphine and Hydromorphone carpujects (manufactured by Hospira) that have been overfilled by as much as two times the expected amount. While this not a recall notice, the FDA encourages a visual inspection of on hand inventory of these items. Below is a list of the items Bound Tree Medical distributes that meet the descriptions provided.

BTM item #

description

Hospira item #

371120

C2  MORPHINE 2MG/ML 1ML  CPJ 10/BX LL SLM CS20

01762-30

371121

C2 MORPHINE 4MG/ML 1ML CPJ 10/BX LL SLM CS21

01258-30

1260-69

C2 MORPHINE 8MG/ML 1ML CPJT 10/BX

01260-69

371123

C2 MORPHINE 10MG/ML  1ML CPJ 10/BX LL SLM CS23

01261-30

1264-31

C2 MORPHINE, 15 MG, 1 ML LUER LOCK CARPUJECT, 10/BX

01264-31

1312-30

C2 HYDROMORPHONE 2MG/ML 1ML CPJ 10/BX

01312-30

Hospira Carpuject Pre-filled Cartridges - Drug Alert: Products May Contain More Than the Intended Fill Volume

AUDIENCE: Risk Manager, Health Professional

ISSUE: FDA is alerting healthcare providers of a potential safety risk in some Carpuject pre-filled cartridges manufactured by Hospira, Inc. The pre-filled cartridges containing the products listed in the Drug Alert may be overfilled by at least twice the expected amount, resulting in potential overdose.

Because pharmacists and other healthcare providers can visually identify the presence of an overfilled Carpuject pre-filled cartridge, FDA is recommending that these steps be taken at this time rather than a product recall, because a recall of the affected products would result in an immediate shortage. 

BACKGROUND: Hospira, Inc. has informed the FDA of the occurrence of overfilled Carpuject pre-filled cartridges containing morphine and hydromorphone following complaints received from healthcare providers.

Subsequent inspection of retained product by Hospira found additional overfilled Carpuject pre-filled cartridges. The manufacturing problem thought to be responsible for this overfilling has resulted in the risk for overfilled Carpuject pre-filled cartridges for as many as 280 lots of 15 different Carpuject pre-filled cartridge products.

RECOMMENDATION: FDA is advising healthcare providers to follow the instructions provided with the medication and visually inspect and confirm that the Carpuject pre-filled cartridge contains the labeled fill volume before dispensing and again before administering to patients.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Read the MedWatch safety alert, including links to the drug alert and instructions for health professionals, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305236.htm

 

Back to News

News Archive

Navigation